These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34399099)

  • 1. Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery.
    Cazzaniga G; Mori M; Chiarelli LR; Gelain A; Meneghetti F; Villa S
    Eur J Med Chem; 2021 Nov; 224():113732. PubMed ID: 34399099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis.
    Mori M; Villa S; Ciceri S; Colombo D; Ferraboschi P; Meneghetti F
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents.
    Farah SI; Abdelrahman AA; North EJ; Chauhan H
    Assay Drug Dev Technol; 2016; 14(1):29-38. PubMed ID: 26565779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-mycobacterial natural products and mechanisms of action.
    Han J; Liu X; Zhang L; Quinn RJ; Feng Y
    Nat Prod Rep; 2022 Jan; 39(1):77-89. PubMed ID: 34226909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and revisited approaches in antituberculosis drug discovery.
    Herrmann J; Rybniker J; Müller R
    Curr Opin Biotechnol; 2017 Dec; 48():94-101. PubMed ID: 28427007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antimicrobial peptides against Mycobacterium tuberculosis.
    Abedinzadeh M; Gaeini M; Sardari S
    J Antimicrob Chemother; 2015 May; 70(5):1285-9. PubMed ID: 25681127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update.
    Kumar G; C A
    Drug Dev Res; 2023 Aug; 84(5):779-804. PubMed ID: 37086027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in natural product-based drug discovery for tuberculosis.
    Dong M; Pfeiffer B; Altmann KH
    Drug Discov Today; 2017 Mar; 22(3):585-591. PubMed ID: 27890820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery.
    de Melo Milani V; Silva ML; Camargo PG; de Lima Ferreira Bispo M
    Curr Med Chem; 2024; 31(29):4703-4724. PubMed ID: 38375848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of marine natural Products: Recent Advances in the discovery of Anti-Tuberculosis agents.
    Peng X; Zeng Z; Hassan S; Xue Y
    Bioorg Chem; 2024 Oct; 151():107699. PubMed ID: 39128242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target discovery focused approaches to overcome bottlenecks in the exploitation of antimycobacterial natural products.
    Baptista R; Bhowmick S; Nash RJ; Baillie L; Mur LA
    Future Med Chem; 2018 Apr; 10(7):811-822. PubMed ID: 29569936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising Antimycobacterial Activities of Flavonoids against
    Rabaan AA; Alhumaid S; Albayat H; Alsaeed M; Alofi FS; Al-Howaidi MH; Turkistani SA; Alhajri SM; Alahmed HE; Alzahrani AB; Mashraqi MM; Alwarthan S; Alhajri M; Alshahrani FS; Almuthree SA; Alsubki RA; Abuzaid AA; Alfaresi M; Al Fares MA; Mutair AA
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Compounds for Overcoming Multidrug Resistance in Mycobacteria.
    Sharma S; Hameed S; Fatima Z
    Recent Pat Biotechnol; 2016; 10(2):167-174. PubMed ID: 27652611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.
    Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; de Logu A; Manetti F; Botta M
    ChemMedChem; 2011 Apr; 6(4):593-9. PubMed ID: 21341373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tuberculosis: a glimpse of promising drug targets.
    Arora N; Banerjee AK
    Mini Rev Med Chem; 2012 Mar; 12(3):187-201. PubMed ID: 22356190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.